In a dengue patient presenting with pulmonary congestion, could this indicate heart failure and what is the appropriate management?

Dengue with Pulmonary Congestion and Possible Heart Failure

In dengue patients presenting with pulmonary congestion, this can indeed indicate cardiac involvement including myocarditis and heart failure, requiring urgent echocardiographic assessment and cautious fluid management to avoid worsening cardiac decompensation.

Understanding Dengue Cardiovascular Pathophysiology

Dengue presents a unique and complex cardiovascular challenge that differs fundamentally from typical heart failure. The pathophysiology evolves through distinct temporal phases 1:

• Febrile phase: Direct viral myocardial effects and endothelial glycocalyx disruption
• Critical phase: Vascular leak peaks (typically resolves within 48-72 hours of defervescence)
• Recovery phase: Myocardial dysfunction may persist up to 2 weeks, creating a dangerous temporal dissociation

The critical insight is that dengue shock represents a mixed phenotype with approximately equal contributions of hypovolemic and cardiogenic shock 1. This creates a narrow therapeutic window where aggressive fluid resuscitation can precipitate pulmonary edema and worsen cardiac dysfunction.

Cardiac Involvement in Dengue

Cardiovascular complications occur in 12-50% of hospitalized dengue patients 2 and include:

• Myocarditis (most common cardiac manifestation) 3
• Rhythm abnormalities
• Pericarditis
• Deterioration in myocardial function
• Cardiogenic shock 4, 5

Raised cardiac troponin I is present in 100% of dengue myocarditis cases and is a predictor of both prolonged hospital stay and in-hospital mortality 6.

Immediate Diagnostic Approach

Essential Investigations

1. Urgent echocardiography 7, 8

   • Assess left and right ventricular function
   • Measure ejection fraction (24% of dengue myocarditis patients have EF <55%) 6
   • Evaluate for pericardial effusion
   • Exclude mechanical complications

2. Cardiac biomarkers

   • Troponin I (elevated in all dengue myocarditis cases) 6
   • Natriuretic peptides (BNP/NT-proBNP)

3. ECG monitoring

   • 59.5% of dengue myocarditis patients show ECG changes 6
   • Continuous monitoring for arrhythmias

4. Hemodynamic assessment

   • Blood pressure trends (look for narrow pulse pressure, cool extremities indicating hypoperfusion) 8
   • Oxygen saturation
   • Urine output
   • Signs of congestion vs. hypoperfusion

Critical Management Algorithm

Step 1: Determine Shock Phenotype

Assess for mixed shock (hypovolemic + cardiogenic components):

• Hypovolemic features: Hemoconcentration, low filling pressures, tachycardia
• Cardiogenic features: Pulmonary congestion, elevated troponin, reduced EF on echo, cool extremities

Step 2: Oxygen and Ventilatory Support

• Supplemental oxygen if SpO₂ <90% 9
• Non-invasive ventilation (CPAP/BiPAP) for respiratory distress with pulmonary edema 10, 9
• Intubation if severe respiratory failure 7

Step 3: Fluid Management - THE CRITICAL DECISION

This is where dengue differs dramatically from typical heart failure:

If predominantly hypovolemic (early critical phase, no cardiac dysfunction on echo):

• Cautious crystalloid boluses with frequent reassessment
• Monitor for signs of fluid overload

If pulmonary congestion with cardiac dysfunction (myocarditis confirmed):

• AVOID aggressive fluid resuscitation 1, 4
• Use diuretics cautiously - low to intermediate dose furosemide only if volume overload is confirmed 11
• Critical caveat: Diuretics should be used with extreme caution in dengue patients who have not received adequate volume expansion during the leak phase 11

Step 4: Pharmacologic Management

For pulmonary congestion with preserved blood pressure (SBP >100 mmHg):

• Nitrates (IV nitroglycerin) for preload reduction 11, 10

  • Contraindicated if SBP <100 mmHg or >30 mmHg below baseline 11
  • Reduces venous preload and arterial afterload
  • Increases coronary blood flow

• Diuretics (furosemide, torsemide, or bumetanide) 11

  • Only if associated volume overload is confirmed
  • Use low to intermediate doses
  • Extreme caution in dengue - must ensure adequate intravascular volume first

For pulmonary congestion with hypotension (SBP <100 mmHg):

• Inotropic support (dobutamine, milrinone) 11
• Vasopressor support if needed 11
• Consider intra-aortic balloon pump (IABP) for refractory cases 11

Critical medications to AVOID:

• Do NOT give beta-blockers or calcium channel blockers acutely to patients with frank cardiac failure evidenced by pulmonary congestion 11
• Do NOT give IV ACE inhibitors in the first 24 hours due to hypotension risk 12

Step 5: Monitoring and Supportive Care

• Continuous ECG monitoring 9
• Frequent vital signs (every 15-30 minutes initially)
• Strict intake/output monitoring
• Serial troponin measurements
• Consider pulmonary artery catheter if cardiogenic shock and hemodynamic uncertainty 11, 7

Common Pitfalls to Avoid

1. Over-resuscitation with fluids: The most dangerous error in dengue with cardiac involvement. The temporal dissociation between vascular leak resolution (48-72 hours) and persistent myocardial dysfunction (up to 2 weeks) creates a window where aggressive fluids cause pulmonary edema 1, 4.

2. Assuming pure hypovolemic shock: Dengue shock is mixed in nature. Always assess for cardiac dysfunction with echo 1.

3. Premature diuretic use: In early dengue, patients may still be in the vascular leak phase requiring volume. Diuretics before adequate resuscitation can precipitate shock 11.

4. Missing myocarditis: Check troponin in all dengue patients with respiratory distress or hemodynamic instability 6.

5. Delaying echocardiography: Echo should be performed urgently, not after "stabilization" 7, 8.

Prognosis and Follow-up

• Myocardial dysfunction typically improves over 2-4 weeks 4
• Repeat echocardiography at 3 months to document recovery 4
• Risk of heart failure admission is highest in the first week post-dengue (IRR 56.50), particularly in patients >60 years 13
• Raised troponin and abnormal echo predict prolonged hospital stay and mortality 6

The key to managing dengue with pulmonary congestion is recognizing the mixed shock phenotype, performing urgent echocardiography, and avoiding the reflexive aggressive fluid resuscitation that would be appropriate for pure hypovolemic shock but is potentially fatal when cardiac dysfunction is present.